Company Overview
GOSSAMER BIO, INC.
GOSSRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
91M
2025 FY
Net Income
-170M
2025 FY
Shares Outstanding
229M
2025 FY
EPS
-0.75USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1728117
Exchange
Nasdaq
Location
US